BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li QY, Miao Q, Sui RX, Cao L, Ma CG, Xiao BG, Xiao W, Yu WB. Ginkgolide K supports remyelination via induction of astrocytic IGF/PI3K/Nrf2 axis. Int Immunopharmacol 2019;75:105819. [PMID: 31421546 DOI: 10.1016/j.intimp.2019.105819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gorter RP, Baron W. Recent insights into astrocytes as therapeutic targets for demyelinating diseases. Curr Opin Pharmacol 2022;65:102261. [PMID: 35809402 DOI: 10.1016/j.coph.2022.102261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wang T, Wu Z, Yang C, Cao L, Wang Z, Cao Z, Yu M, Zhao M, Zhang C, Liu W, Zhao B, Shang X, Feng Y, Wang H, Deng L, Xiao B, Guo H, Xiao W. Multiple Mechanistic Models Reveal the Neuroprotective Effects of Diterpene Ginkgolides against Astrocyte-Mediated Demyelination via the PAF-PAFR Pathway. Am J Chin Med 2022;50:1565-1597. [DOI: 10.1142/s0192415x22500665] [Reference Citation Analysis]
3 Abd El Aziz AE, Sayed RH, Sallam NA, El Sayed NS. Neuroprotective Effects of Telmisartan and Nifedipine Against Cuprizone-Induced Demyelination and Behavioral Dysfunction in Mice: Roles of NF-κB and Nrf2. Inflammation 2021;44:1629-42. [PMID: 33709265 DOI: 10.1007/s10753-021-01447-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 De Nuccio C, Bernardo A, Troiano C, Brignone MS, Falchi M, Greco A, Rosini M, Basagni F, Lanni C, Serafini MM, Minghetti L, Visentin S. NRF2 and PPAR-γ Pathways in Oligodendrocyte Progenitors: Focus on ROS Protection, Mitochondrial Biogenesis and Promotion of Cell Differentiation. Int J Mol Sci 2020;21:E7216. [PMID: 33003644 DOI: 10.3390/ijms21197216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]